Kee Song Bio-Technology Holdings Limited announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 563.452 million compared to TWD 633.927 million a year ago. Operating income was TWD 33.448 million compared to TWD 33.219 million a year ago. Net income was TWD 24.629 million compared to TWD 33.770 million a year ago. Basic earnings per share was TWD 0.66 compared to TWD 0.91 a year ago. Diluted earnings per share was TWD 0.57 compared to TWD 0.91 a year ago. For the half year, sales was TWD 1,140.791 million compared to TWD 1,354.973 million a year ago. Operating income was TWD 58.047 million compared to operating loss of TWD 12.739 million a year ago. Net income was TWD 41.049 million compared to net loss of TWD 23.082 million a year ago. Basic earnings per share was TWD 1.11 compared to basic loss per share of TWD 0.63 a year ago. Diluted earnings per share was TWD 0.97 compared to diluted loss per share of TWD 0.63 a year ago.